<DOC>
	<DOCNO>NCT02468349</DOCNO>
	<brief_summary>The propose research aim compare Left ventricular remodel outcome among patient AMI elevate NT-pro-B-type natriuretic peptide receive telemedicine-guided post-MI treatment vs. non-telemedicine guided treatment .</brief_summary>
	<brief_title>IMproving reModeling Acute myoCardial Infarction Using Live Asynchronous TElemedicine .</brief_title>
	<detailed_description>Acute Myocardial Infarction ( AMI ) account 6,000 admission Singapore hospital year . Contemporary treatment , include percutaneous intervention ( angioplasty stenting ) adjunctive drug therapy , reduce early mortality AMI . In many healthcare system , Hospital scorecard stipulate prescription appropriate drug upon discharge hospitalization AMI . These drug include aspirin , platelet P2Y12 inhibitor , angiotensin convert enzyme inhibitor ( ACE-I ) angiotensin receptor blocker ( ARB ) , beta-blockers lipid-lowering drug . Such quality improvement program lead increase prescription drug upon discharge . Yet , 2 problem remain pervasive : 1. dose optimisation ; escalate patient effective drug dos , 2. drug adherence ; whether patient take drug regularly . These 2 problem stem largely traditional model episodic care entail face-to-face visit patient healthcare practitioner . Inadequate dose optimisation relevant ACE-I/ARB beta-blockers healthcare practitioner necessarily prescribe low dos drug discharge avoid excessive lower blood pressure soon AMI . Yet , drug effective prevent adverse ventricular remodel patient take maximum tolerated dos . In clinical trial , titrate ACE-I/ARB beta-blockers target dos required weekly outpatient visit , model care healthcare system afford . We hypothesize telemedicine-based system care lead great reduction ventricular remodel compare usual care , improve dose optimisation adherence ACE-I/ARB beta-blockers patient recent AMI . Participants AMI ( n=300 ) recruit index hospitalization . A key inclusion criterion elevate NT-proBNP measurement index hospitalization . Participants first undergo stratify randomization accord ST-segment classification ( STEMI/NSTEMI ) , thereafter randomize Telehealth versus Control group 1:1 sequential block randomization ( block 4 6 ) . The telehealth intervention group blood pressure heart rate monitor twice daily home 2 month , alternate titration ACE-inhibitors betablockers weekly first 2 month . After 2 month , continue telemedicine consultation 4 month ; coach drug adherence , drug side-effects management monitoring symptom . A smartphone-based app develop PEACH Intellihealth provide structure health education , medication reminder real-time text message telehealth professional . All participant enrol put 1 year dual antiplatelet therapy , cardiac MRI do baseline 6-months , follow cardiologist review visit 1 , 6 12 month . Major adverse cardiovascular cerebrovascular event assess cardiologist review visit , beyond 12 month , assess either phone-calls online/mailed questionnaire 18 24 month . Four substudies plan : substudy assess impact telemedicine readmission ( ALTRA ) , substudy assess effect telemedicine adherence antiplatelet therapy ( TICA ) , substudy assess cost-effectiveness telemedicine ( CEA ) substudy assess effect telemedicine MR-PET measure cardiac work efficiency ( CES ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ventricular Remodeling</mesh_term>
	<criteria>Inclusion criterion 1 . Clinically diagnosed STEMI NSTEMI* within last 7 day high risk ventricular remodel Typical history ischemic chest pain angina equivalent symptom ( e.g . acute onset dyspnea ) Typical rise fall cardiac enzymes least one value cardiac troponin I≥10 ug/L . ECG change require diagnosis STEMI : ≥0.1mV ST segment elevation two contiguous limb lead precordial lead presence Q wave ≥0.02 sec two contiguous limb lead precordial lead , new onset leave bundle branch block ( LBBB ) , *The definition STEMI NSTEMI follow 3rd universal definition MI [ 19 ] 2 . Predischarge NTproBNP ≥400 pg/mL STEMI 600 pg/mL NSTEMI 3 . Undergone PCI index event 4 . Age &gt; 21 year &lt; 85 year Exclusion criteria 1 . Hypersensitivity ticagrelor , aspirin excipients 2 . Active pathological bleeding 3 . History intracranial haemorrhage 4 . Bacterial Infection within 6 week precede primary angioplasty , HIV , autoimmune disease ( e.g . SLE , rheumatoid arthritis , scleroderma Grave 's disease , etc ) immunosuppressive therapy 5 . Women childbearing potential , know pregnant , breastfeeding , intend become pregnant study period 6 . Malignancy within last 2 year 7 . History significant valvular heart disease ( moderate severe MS , MR , AS , AR , TR ) 8 . Planned CABG within next 6 week 9 . Unable weaned inotropes IABP 10 . Active asthma contraindication betablockers 11 . Arrhythmias preclude proper CMR image acquisition , atrial fibrillation frequent atrial ventricular ectopy &gt; 1 5 intrinsic QRS complex 12 . Contraindications cardiac magnetic resonance image include claustrophobia , pacemaker ICD implantation , mechanical valve metallic implant 13 . Severe liver impairment due chronic liver disease e.g . advanced alcoholic liver cirrhosis primary biliary cirrhosis 14 . Significant renal impairment ( eGFR &lt; 50ml min1 ) , end stage renal failure renal replacement therapy 15 . Anaemia ( Hb &lt; 10 g/dL ) . 16 . Psychosocial barrier telemedicine adoption ( screen education level , dementia , substance abuse psychological disorder ) 17 . Participants follow 18 . Participants able willing consent study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Telemedicine</keyword>
	<keyword>Readmissions</keyword>
</DOC>